L-Carnosine
beta-alanyl-L-histidine
TL;DR
L-Carnosine is a dipeptide that buffers acid in muscle and blocks glycation (sugar-protein cross-linking) in the lab. Human data are thin: most exercise benefits come from supplementing its precursor beta-alanine instead, and the anti-ageing claims rest largely on cell and animal work.
Ideal For
- People specifically interested in glycation and advanced glycation end-products
- Those who cannot tolerate the tingling of beta-alanine and want a low-risk alternative
Avoid If
- You are pregnant or breastfeeding
- You want proven strength or endurance gains (use beta-alanine)
- You expect reversal of ageing markers — human evidence does not support this
Frequently Asked Questions
Overview
Carnosine is made in the body from beta-alanine and histidine, and it sits in high concentrations in skeletal muscle, heart and brain. Interest comes from three properties: it buffers hydrogen ions during hard exercise, it scavenges reactive carbonyls, and it chelates transition metals. The practical catch is that oral carnosine is rapidly broken down by serum carnosinase, so plasma carnosine barely rises. That is why sports science uses beta-alanine — the rate-limiting precursor — to raise intramuscular carnosine, while carnosine itself is mostly studied for glycation, eye health (as N-acetylcarnosine drops) and small autism and diabetes trials. Treat the anti-ageing marketing as hypothesis, not finding.
How It Works
- Buffers intramuscular hydrogen ions during high-intensity effort
- Scavenges reactive carbonyl species and inhibits advanced glycation end-product formation
- Chelates copper and zinc, limiting metal-catalysed oxidation
- Rapidly hydrolysed by serum carnosinase after oral dosing, limiting systemic exposure
Quick Facts
- Potent antioxidant
- Anti-glycation effects
- Neuroprotective properties
- Muscle pH buffering
- Longevity support
Health Concerns Addressed
No linked health concerns yet.
Supporting Research6 studies
Effect of Carnosine or beta-Alanine Supplementation on Markers of Glycemic Control and Insulin Resistance in Humans and Animals: A Systematic Review and Meta-analysis
Matthews JJ, Dolan E, Swinton PA +5 more
Pooled human trials showed carnosine or beta-alanine supplementation reduced HbA1c and fasting glucose in participants with impaired glucose metabolism, with little effect in metabolically healthy individuals.
L-carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor-alpha levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial
Houjeghani S, Kheirouri S, Faraji E +1 more
l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor-alpha levels in patients with type 2 diabetes
N-acetylcarnosine (NAC) drops for age-related cataract
Dubois VD, Bastawrous A
The protein, L-carnosine, is known to have an antioxidant effect on the cataractous lens.
Effect of carnosine or beta-alanine supplementation therapy for prediabetes or type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
Li N, Yan X, Lin J +2 more
Carnosine supplementation significantly lowered HbA1c and improved insulin resistance versus placebo in prediabetes and type 2 diabetes, while effects on fasting insulin were not significant.
Effect of carnosine supplementation on lipid profile, fasting blood glucose, HbA1C and insulin resistance: A systematic review and meta-analysis of long-term randomized controlled trials
Peng W, Mao P, Liu L +8 more
Four RCTs studies investigated Carnosine use versus any control for at least 2 weeks were identified and analyzed.
Effects of Carnosine Supplementation on Cognitive Outcomes in Prediabetes and Well-Controlled Type 2 Diabetes: A Randomised Placebo-Controlled Clinical Trial
Hariharan R, Mousa A, Menon K +2 more
Fourteen weeks of carnosine supplementation did not improve any cognitive domain compared with placebo in adults with prediabetes or well-controlled type 2 diabetes.
Safety Information
Potential Side Effects
Generally well tolerated. Occasional mild GI upset. Very high doses have been anecdotally linked to hyperactivity or restlessness in children.
Contraindications
No absolute contraindications established; avoid in pregnancy and lactation due to absent data.
Drug Interactions
- None well documented; theoretical additive effect with zinc supplements when using zinc-carnosine
Pregnancy & Breastfeeding
Pregnancy: insufficient_data
Breastfeeding: insufficient_data
Dosage Guidelines
Dosage Used in Studies
500-1500 mg
Best Time to Take
Any time of day; split doses if using 1 g or more
Best Form
Plain L-carnosine for general use; beta-alanine if the goal is exercise performance
Bioavailability
Poor systemically — serum carnosinase hydrolyses most of an oral dose within an hour
Dosing by Goal
| Goal | Dose | Notes |
|---|---|---|
| 500-1000 mg/day | Doses used in small diabetes and autism trials | |
| Use beta-alanine 3.2-6.4 g/day instead | Beta-alanine raises muscle carnosine; oral carnosine largely does not |
Forms Compared
Standard oral form; degraded by serum carnosinase
Different molecule studied for gastric mucosa, not interchangeable
Studied for cataract; separate topical use
Food & Timing
Food is optional and does not meaningfully change tolerance
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.